{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T21:35:13Z","timestamp":1791581713865,"version":"4.3.4"},"reference-count":65,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1016\/j.ejmech.2023.115681","type":"journal-article","created":{"date-parts":[[2023,7,25]],"date-time":"2023-07-25T04:24:10Z","timestamp":1690259050000},"page":"115681","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"special_numbering":"C","title":["Development of novel bosentan analogues as endothelin receptor antagonists for pulmonary arterial hypertension"],"prefix":"10.1016","volume":"259","author":[{"given":"Jigar","family":"Panchal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shivangi","family":"Jaiswal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonika","family":"Jain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jyoti","family":"Kumawat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashima","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pankaj","family":"Jain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Smita","family":"Jain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kanika","family":"Verma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1524-7714","authenticated-orcid":false,"given":"Jaya","family":"Dwivedi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Swapnil","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2023.115681_bib1","doi-asserted-by":"crossref","DOI":"10.1183\/16000617.0211-2022","article-title":"New trends in pulmonary hypertension","volume":"32","author":"Cullivan","year":"2023","journal-title":"Eur. Respir. Rev."},{"key":"10.1016\/j.ejmech.2023.115681_bib2","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/S2213-2600(15)00542-1","article-title":"Treatment of pulmonary hypertension","volume":"4","author":"Hoeper","year":"2016","journal-title":"Lancet Respir. Med."},{"key":"10.1016\/j.ejmech.2023.115681_bib3","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/S2213-2600(15)00543-3","article-title":"A global view of pulmonary hypertension","volume":"4","author":"Hoeper","year":"2016","journal-title":"Lancet Respir. Med."},{"key":"10.1016\/j.ejmech.2023.115681_bib4","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1136\/jim-2020-001291","article-title":"Clinical update on pulmonary hypertension","volume":"68","author":"Yaghi","year":"2020","journal-title":"J. Invest. Med."},{"key":"10.1016\/j.ejmech.2023.115681_bib5","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.1002\/jhet.4343","article-title":"Greener approach toward synthesis of biologically active s\u2010Triazine (TCT) derivatives: a recent update","volume":"58","author":"Panchal","year":"2021","journal-title":"J. Heterocycl. Chem."},{"key":"10.1016\/j.ejmech.2023.115681_bib6","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.2174\/1389557522666220510113702","article-title":"Comprehensive update on synthetic aspects of bosentan derivatives","volume":"23","author":"Panchal","year":"2023","journal-title":"Mini Rev. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115681_bib7","doi-asserted-by":"crossref","first-page":"104","DOI":"10.2174\/1573398X18666220217151152","article-title":"A literature review of pulmonary arterial hypertension (PAH)","volume":"18","author":"Panchal","year":"2022","journal-title":"Curr. Respir. Med. Rev."},{"key":"10.1016\/j.ejmech.2023.115681_bib8","first-page":"491","article-title":"Process for the preparation of bosentan","volume":"12\/332","author":"Taddei","year":"2009","journal-title":"U.S. Patent Application"},{"key":"10.1016\/j.ejmech.2023.115681_bib9","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1139\/y03-008","article-title":"The endothelin system in pulmonary hypertension","volume":"81","author":"Michel","year":"2003","journal-title":"Can. J. Physiol. Pharmacol."},{"key":"10.1016\/j.ejmech.2023.115681_bib10","series-title":"U.S. Patent 5420129A","author":"Breu","year":"1995"},{"key":"10.1016\/j.ejmech.2023.115681_bib11","series-title":"U.S. Patent 6136971A","author":"Harrington","year":"2000"},{"key":"10.1016\/j.ejmech.2023.115681_bib12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/molecules25081851","article-title":"Synthesis and molecular modelling studies of new 1,3-diaryl-5-oxo-proline derivatives as endothelin receptor ligands","volume":"25","author":"Intagliata","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2023.115681_bib13","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1038\/s12276-021-00678-9","article-title":"A human antibody against human endothelin receptor type A that exhibits antitumor potency","volume":"53","author":"Ju","year":"2021","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.ejmech.2023.115681_bib14","doi-asserted-by":"crossref","first-page":"3083","DOI":"10.1016\/S0006-3495(00)76543-X","article-title":"Modeling and docking the endothelin G-protein-coupled receptor","volume":"79","author":"Orry","year":"2000","journal-title":"Biophys. J."},{"key":"10.1016\/j.ejmech.2023.115681_bib15","doi-asserted-by":"crossref","first-page":"918","DOI":"10.2174\/1389557517666170927160919","article-title":"The synthetic and biological attributes of pyrazole derivatives: a review","volume":"18","author":"Dwivedi","year":"2018","journal-title":"Mini Rev. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115681_bib16","doi-asserted-by":"crossref","first-page":"3689","DOI":"10.1002\/jhet.3003","article-title":"Synthesis of novel substituted phenyl\u20103\u2010hydrazinyl\u2010quinoxaline\u20102\u2010amine derivatives: evaluation of antimicrobial activity and its molecular docking studies","volume":"54","author":"Paliwal","year":"2017","journal-title":"J. Heterocycl. Chem."},{"key":"10.1016\/j.ejmech.2023.115681_bib17","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1080\/00304948.2016.1234826","article-title":"Improved large-scale synthesis of bosentan monohydrate","volume":"48","author":"Raju","year":"2016","journal-title":"Org. Prep. Proced. Int."},{"key":"10.1016\/j.ejmech.2023.115681_bib18","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1021\/op400100s","article-title":"A new efficient synthetic process for an endothelin receptor antagonist","volume":"17","author":"Rebelli","year":"2013","journal-title":"Bosentan Monohydrate. Org. Process Res. Dev."},{"key":"10.1016\/j.ejmech.2023.115681_bib19","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.3390\/ph15101227","article-title":"Monocrotaline-induced pulmonary arterial hypertension and bosentan treatment in rats: focus on plasma and erythrocyte parameters","volume":"15","author":"Jasenovec","year":"2022","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.ejmech.2023.115681_bib20","doi-asserted-by":"crossref","first-page":"147","DOI":"10.3109\/13880209.2014.912240","article-title":"Withania somnifera shows a protective effect in monocrotaline-induced pulmonary hypertension","volume":"53","author":"Kaur","year":"2015","journal-title":"Pharm. Biol."},{"key":"10.1016\/j.ejmech.2023.115681_bib21","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.3389\/fphar.2018.01032","article-title":"Maprotiline prevents monocrotaline-induced pulmonary arterial hypertension in rats","volume":"9","author":"Tong","year":"2018","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ejmech.2023.115681_bib22","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.lfs.2018.03.045","article-title":"Cardioprotective effect of cerium oxide nanoparticles in monocrotaline rat model of pulmonary hypertension: a possible implication of endothelin-1","volume":"201","author":"Nassar","year":"2018","journal-title":"Life Sci."},{"key":"10.1016\/j.ejmech.2023.115681_bib23","doi-asserted-by":"crossref","first-page":"2152","DOI":"10.3390\/antiox11112152","article-title":"Effect of empagliflozin on thioacetamide-induced liver injury in rats: role of AMPK\/SIRT-1\/HIF-1\u03b1 pathway in halting liver fibrosis","volume":"11","author":"ElBaset","year":"2022","journal-title":"Antioxidants"},{"key":"10.1016\/j.ejmech.2023.115681_bib24","article-title":"In silico identification of potential inhibitors of key SARS-CoV-2 3CL hydrolase (Mpro) via molecular docking, MMGBSA predictive binding energy calculations, and molecular dynamics simulation","volume":"15","author":"Choudhary","year":"2023","journal-title":"PLoS One"},{"key":"10.1016\/j.ejmech.2023.115681_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.114952","article-title":"Development of potent and selective FAAH inhibitors with improved drug-like properties as potential tools to treat neuroinflammatory conditions","volume":"246","author":"Papa","year":"2023","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115681_bib26","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0011111","article-title":"Gene expression of ANP, BNP and ET-1 in the heart of rats during pulmonary embolism","volume":"5","author":"Gutte","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.ejmech.2023.115681_bib27","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1080\/13880209.2020.1723648","article-title":"Dendrobium candidum aqueous extract attenuates isoproterenol-induced cardiac hypertrophy through the ERK signalling pathway","volume":"58","author":"Cao","year":"2020","journal-title":"Pharm. Biol."},{"key":"10.1016\/j.ejmech.2023.115681_bib28","article-title":"Anti-inflammatory effects of the Chinese herbal formula sini tang in myocardial infarction rats","volume":"2014","author":"Liu","year":"2014","journal-title":"Evid.-Based Compl. Altern. Med."},{"key":"10.1016\/j.ejmech.2023.115681_bib29","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1139\/y2012-011","article-title":"Fluoxetine protects against monocrotaline-induced pulmonary arterial remodeling by inhibition of hypoxia-inducible factor-1\u03b1 and vascular endothelial growth factor","volume":"90","author":"Han","year":"2012","journal-title":"Can. J. Physiol. Pharmacol."},{"key":"10.1016\/j.ejmech.2023.115681_bib30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40360-019-0304-z","article-title":"Effects of neprilysin-renin inhibition in comparison with neprilysin-angiotensin inhibition on the neurohumoral changes in rats with heart failure","volume":"20","author":"Dizaye","year":"2019","journal-title":"BMC Pharmacol. Toxicol"},{"key":"10.1016\/j.ejmech.2023.115681_bib31","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1177\/0192623309339502","article-title":"Qualification of cardiac troponin I concentration in mouse serum using isoproterenol and implementation in pharmacology studies to accelerate drug development","volume":"37","author":"Engle","year":"2009","journal-title":"Toxicol. Pathol."},{"key":"10.1016\/j.ejmech.2023.115681_bib32","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12906-020-03124-x","article-title":"Cardioprotective potential of polyphenols rich Thraatchathi Chooranam against isoproterenol induced myocardial necrosis in experimental rats","volume":"20","author":"Ganapathy","year":"2020","journal-title":"BMC complement. Med. Ther."},{"key":"10.1016\/j.ejmech.2023.115681_bib33","article-title":"Antioxidant properties and cardioprotective mechanism of Malaysian propolis in rats","volume":"2017","author":"Ahmed","year":"2017","journal-title":"Evid. Based Compl. Alternat. Med."},{"key":"10.1016\/j.ejmech.2023.115681_bib34","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1164\/rccm.201710-2079OC","article-title":"Therapeutic targeting of vascular remodeling and right heart failure in pulmonary arterial hypertension with a HIF-2\u03b1 inhibitor","volume":"198","author":"Dai","year":"2018","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.ejmech.2023.115681_bib35","doi-asserted-by":"crossref","first-page":"4824","DOI":"10.3390\/nu14224824","article-title":"Chickpea peptide: a nutraceutical molecule corroborating neurodegenerative and ACE-I inhibition","volume":"14","author":"Gupta","year":"2022","journal-title":"Nutrients"},{"key":"10.1016\/j.ejmech.2023.115681_bib36","first-page":"1","article-title":"Liraglutide prevents and reverses monocrotaline-induced pulmonary arterial hypertension by suppressing ET-1 and enhancing eNOS\/sGC\/PKG pathways","volume":"6","author":"Lee","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejmech.2023.115681_bib37","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1007\/s10753-019-01061-7","article-title":"Uremic serum induces inflammation in cultured human endothelial cells and triggers vascular repair mechanisms","volume":"42","author":"Eloueyk","year":"2019","journal-title":"Inflammation"},{"key":"10.1016\/j.ejmech.2023.115681_bib38","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/j.tips.2017.03.003","article-title":"Targeting the prostacyclin pathway: beyond pulmonary arterial hypertension","volume":"38","author":"Pluchart","year":"2017","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.ejmech.2023.115681_bib39","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.tcm.2009.04.003","article-title":"Cyclooxygenase-2 inhibition and hypoxia-induced pulmonary hypertension: effects on pulmonary vascular remodeling and contractility","volume":"19","author":"Fredenburgh","year":"2009","journal-title":"Trends Cardiovasc. Med."},{"key":"10.1016\/j.ejmech.2023.115681_bib40","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.3390\/ijms18061125","article-title":"Melatonin attenuates pulmonary hypertension in chronically hypoxic rats","volume":"18","author":"Hung","year":"2017","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejmech.2023.115681_bib41","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1007\/s00134-012-2484-5","article-title":"Haemodynamic and neuroendocrine effects of tezosentan in chronic experimental pulmonary hypertension","volume":"38","author":"Louren\u00e7o","year":"2012","journal-title":"Intensive Care Med."},{"key":"10.1016\/j.ejmech.2023.115681_bib42","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.repc.2013.09.016","article-title":"Myocardial and anti-inflammatory effects of chronic bosentan therapy in monocrotaline-induced pulmonary hypertension","volume":"33","author":"Fontoura","year":"2014","journal-title":"Rev. Port. Cardiol."},{"key":"10.1016\/j.ejmech.2023.115681_bib43","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1183\/09031936.00028310","article-title":"Dexamethasone reverses monocrotaline-induced pulmonary arterial hypertension in rats","volume":"37","author":"Price","year":"2011","journal-title":"Eur. Clin. Respir. J."},{"key":"10.1016\/j.ejmech.2023.115681_bib44","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.bbagrm.2018.03.007","article-title":"Suberanilo hydroxamic acid prevents TGF-\u03b21-induced COX-2 repression in human lung fibroblasts post-transcriptionally by TIA-1 downregulation","volume":"1861","author":"Pasini","year":"2018","journal-title":"Biochim. Biophys. Acta Gene Regul. Mech."},{"key":"10.1016\/j.ejmech.2023.115681_bib45","doi-asserted-by":"crossref","DOI":"10.1016\/j.molliq.2023.121364","article-title":"Efficient synthesis of chromeno[2,3-b]pyridine derivatives using Zn(OTf)2 as a catalyst: DFT computations, molecular docking and ADME studies","volume":"375","author":"Serdaro\u011flu","year":"2023","journal-title":"J. Mol. Liq."},{"key":"10.1016\/j.ejmech.2023.115681_bib46","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1007\/s12010-021-03698-3","article-title":"GC\u2013MS Analysis, molecular docking and pharmacokinetic properties of phytocompounds from Solanum torvum unripe fruits and its effect on breast cancer target protein","volume":"194","author":"Saravanan","year":"2022","journal-title":"Appl. Biochem. Biotechnol."},{"key":"10.1016\/j.ejmech.2023.115681_bib47","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.3390\/molecules28031341","article-title":"A combination of in silico ADMET prediction, in vivo toxicity evaluation, and potential mechanism exploration of brucine and brucine N-oxide\u2014a Comparative Study","volume":"28","author":"Gao","year":"2023","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2023.115681_bib48","doi-asserted-by":"crossref","first-page":"10488","DOI":"10.1039\/D3RA00066D","article-title":"Design, synthesis, anticancer evaluation, and in silico ADMET analysis of novel thalidomide analogs as promising immunomodulatory agents","volume":"13","author":"Ramadan","year":"2023","journal-title":"RSC Adv."},{"key":"10.1016\/j.ejmech.2023.115681_bib49","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1039\/C8MD00472B","article-title":"ADMET-score\u2013a comprehensive scoring function for evaluation of chemical drug-likeness","author":"Guan","year":"2019","journal-title":"Medchemcomm"},{"key":"10.1016\/j.ejmech.2023.115681_bib50","doi-asserted-by":"crossref","DOI":"10.3390\/molecules27144372","article-title":"Allostery inhibition of BACE1 by psychotic and meroterpenoid drugs in alzheimer's disease therapy","volume":"27","author":"Ugbaja","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2023.115681_bib51","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2022.106531","article-title":"Therapeutic potential of reserpine in metabolic syndrome: an evidence based study","volume":"186","author":"Verma","year":"2022","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.ejmech.2023.115681_bib52","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12931-022-02056-z","article-title":"Imbalanced prostanoid release mediates cigarette smoke-induced human pulmonary artery cell proliferation","volume":"23","author":"Alqarni","year":"2022","journal-title":"Respir. Res."},{"key":"10.1016\/j.ejmech.2023.115681_bib53","doi-asserted-by":"crossref","DOI":"10.3390\/ijms231710001","article-title":"Molecular pathways in pulmonary arterial hypertension","volume":"23","author":"Shah","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejmech.2023.115681_bib54","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1183\/09031936.00130209","article-title":"Fasudil reduces monocrotaline-induced pulmonary arterial hypertension: comparison with bosentan and sildenafil","volume":"36","author":"Mouchaers","year":"2010","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.ejmech.2023.115681_bib55","unstructured":"P. Joshi, A. Bisht, S. Joshi, D. Semwal, N. K. Nema, J. Dwivedi, S. Sharma, Ameliorating Potential of Curcumin and its Analogue in Central Nervous System Disorders."},{"key":"10.1016\/j.ejmech.2023.115681_bib56","doi-asserted-by":"crossref","DOI":"10.1002\/cbdv.202200540","article-title":"Synthesis and theoretical studies of biologically active thieno nucleus incorporated tri and tetracyclic nitrogen containing heterocyclics scaffolds via suzuki cross\u2010coupling reaction","volume":"19","author":"Sain","year":"2022","journal-title":"Chem. Biodivers."},{"key":"10.1016\/j.ejmech.2023.115681_bib57","doi-asserted-by":"crossref","DOI":"10.1002\/slct.202204710","article-title":"Design, synthesis, antibacterial evaluation and docking studies of triazole and tetrazole linked 1, 4\u2010benzodiazepine nucleus via click approach","volume":"8","author":"Devi","year":"2023","journal-title":"ChemistrySelect"},{"key":"10.1016\/j.ejmech.2023.115681_bib58","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/j.ejmech.2014.01.002","article-title":"The chemistry and biological potential of azetidin-2-ones","volume":"74","author":"Arya","year":"2014","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115681_bib59","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1007\/s00134-012-2484-5","article-title":"Haemodynamic and neuroendocrine effects of tezosentan in chronic experimental pulmonary hypertension","volume":"38","author":"Moreira","year":"2012","journal-title":"Intensive Care Med."},{"key":"10.1016\/j.ejmech.2023.115681_bib60","doi-asserted-by":"crossref","first-page":"7849","DOI":"10.1021\/jm3009103","article-title":"The discovery of N-[5-(4-bromophenyl)-6-[2-[(5-bromo-2-pyrimidinyl) oxy] ethoxy]-4-pyrimidinyl]-N\u2032-propylsulfamide (macitentan), an orally active, potent dual endothelin receptor antagonist","volume":"55","author":"Bolli","year":"2012","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115681_bib61","first-page":"55","article-title":"Modern view on the place of riociguat in the treatment of pulmonary hypertension","volume":"90","author":"Valieva","year":"2018","journal-title":"Ter. Arkh."},{"key":"10.1016\/j.ejmech.2023.115681_bib62","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1038\/nsmb.3450","article-title":"X-ray structures of endothelin ETB receptor bound to clinical antagonist bosentan and its analog","volume":"24","author":"Shihoya","year":"2017","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.ejmech.2023.115681_bib63","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1164\/ajrccm.165.3.2104059","article-title":"ETA and ETB receptors modulate the proliferation of human pulmonary artery smooth muscle cells","volume":"165","author":"Davie","year":"2002","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.ejmech.2023.115681_bib64","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1093\/ajhp\/61.11.1107","article-title":"Bosentan therapy for pulmonary arterial hypertension","volume":"61","author":"Cohen","year":"2004","journal-title":"Am. J. Health Syst. Pharm."},{"key":"10.1016\/j.ejmech.2023.115681_bib65","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.csbj.2019.02.006","article-title":"Ligand-based pharmacophore modeling, virtual screening and molecular docking studies for discovery of potential topoisomerase I inhibitors","volume":"17","author":"Pal","year":"2019","journal-title":"Comput. Struct. Biotechnol. J."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523423006475?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523423006475?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T14:58:24Z","timestamp":1759330704000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523423006475"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":65,"alternative-id":["S0223523423006475"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2023.115681","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development of novel bosentan analogues as endothelin receptor antagonists for pulmonary arterial hypertension","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2023.115681","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"115681"}}